Pakistani authorities on Friday gave their approval for the emergency use of a fifth vaccine, the third being developed in China, as coronavirus cases have risen in recent days, leading the country to June 2020 numbers.
The Pakistani Medicines Regulatory Authority (DRAP) has therefore given the green light to the CoronaVac vaccine, which combines the Chinese-developed Sinopharm, Convidecia, Russian Sputnik V and the vaccine developed by Oxford University and AstraZeneca.
According to the Pakistani television broadcaster Geo TV, the approval was given despite the low effectiveness of CoronaVac as authorities try to face the third wave of infections and reduce the incidence of COVID-19.
Currently, the two previously approved Chinese vaccines and Sputnik V are being used in the vaccination campaign in Pakistan as AstraZeneca ships through the COVAX mechanism, an initiative aimed at ensuring the delivery of these drugs to all countries in the world has not yet taken effect .
The Pakistani Ministry of Health this Friday confirmed 5,312 cases of coronavirus – second consecutive day of more than 5,000 – and 105 deaths, bringing the total to 710,829 and 15,229 respectively.
He also pointed out that 4,116 people are currently in critical condition, while 625,789 have so far recovered from COVID-19, the disease caused by the new coronavirus, including 2,390 in the last 24 hours.
Pakistani authorities limited the areas with the highest incidence and on Tuesday announced a two-week extension of school closings in those areas to help contain the spread of the disease.